Oragenics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.

About OGEN

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. 

CEO
Janet Huffman
CEOJanet Huffman
Employees
3
Employees3
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
1996
Founded1996
Employees
3
Employees3

OGEN Key Statistics

Market cap
3.49M
Market cap3.49M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
72.72K
Average volume72.72K
High today
$0.859
High today$0.859
Low today
$0.7891
Low today$0.7891
Open price
$0.815
Open price$0.815
Volume
50.38K
Volume50.38K
52 Week high
$18.90
52 Week high$18.90
52 Week low
$0.735
52 Week low$0.735

Stock Snapshot

The current Oragenics(OGEN) stock price is $0.83, with a market capitalization of 3.49M. The stock trades at a price-to-earnings (P/E) ratio of -0.05.

On 2026-01-02, Oragenics(OGEN) stock traded between a low of $0.79 and a high of $0.86. Shares are currently priced at $0.83, which is +5.2% above the low and -3.4% below the high.

Oragenics(OGEN) shares are trading with a volume of 50.38K, against a daily average of 72.72K.

During the past year, Oragenics(OGEN) stock moved between $0.74 at its lowest and $18.90 at its peak.

During the past year, Oragenics(OGEN) stock moved between $0.74 at its lowest and $18.90 at its peak.

People also own

Based on the portfolios of people who own OGEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.